WHC is still in active development. Read this to understand our approach.
depiction of YQEZLKZALYSWHR-UHFFFAOYSA-N.svg
tripsit

ketamine

Check on tripsit

psychonaut

Ketamine

Check on psychonaut

isomerdesign

Ketamine

Check on isomerdesign

pubchem

Ketamine

Check on pubchem

druglab

Kétamine

Check on druglab

drugmap

Ketamine

Check on drugmap

drugmap

Ketamine

Check on drugmap

wiki

Ketamine

Check on wiki

wiki

Arketamine

Check on wiki

wiki

Esketamine

Check on wiki

Data

InChI: InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3

Synonyms: Ketamine [INN:BAN],KETAMINE [HSDB],SCHEMBL16103,PMI-150, S-(-)-Ketamine,GTPL4233,Cetamina [INN-Spanish], Cetamina,kitty, S-Ketamin,Ketasol 100,EC 229-804-1,2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone,KETAMINE [MI], Ketanest (TN), 33643-46-8,2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone #,IDI1_000217,dl-Ketamine, Green,2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone,CAS-6740-88-1,NSC70151, T385,NCGC00159480-02,DSSTox_RID_76912,KETAFOL COMPONENT KETAMINE,(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone,Cyclohexanone, (.+-.)-,CI-581,MLS001331674,CLSTA 20,Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+/-)-, Esketamine (USAN/INN),(+-)-Ketamine,2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,Special K, DTXSID6047810,KBio1_000217,Vetalar (Salt/Mix),Q243547, GTPL9152,Ursotamin,Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-,Ketanest,D08098, DSSTox_CID_27787,Special K [street name], Tekam (TN),Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI), KETAMINE HCL,KETAMINE [INN], Ketamine (INN), (S)-(-)-Ketamine,(.+/-.)-2-(O-Chlorophenyl)-2-(methylamino)cyclohexanone,100477-72-3, Dl-Ketamine,DTXSID8023187, CHEMBL395091,Ketolar (Salt/Mix),Kalipsol (Salt/Mix),SCHEMBL17084881, (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone,Clorketam 1000,Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-,NCGC00159480-03,UNII-690G0D6V8H,(+/-)-Ketamine,(+)-Ketamine,Ketanest (Salt/Mix),Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (.+/-.)-,Tekam (TN),Tox21_111703,HMS2272G05, Ketanest,DB01221,(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone, DSSTox_RID_82562, AC1L4AD8,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,Ketoject,KETAMINE HCL,Arketamine (R-enantiomer),DSSTox_CID_3187, 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone,Ketamine (INN), Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-(9CI),Ketamine [INN:BAN], (+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone,Ketaminum [INN-Latin],C07525,Ketalar, Ketalar (TN),NINDS_000217,Ketolar, Esketamine [USAN:INN:BAN],Ketaminum, Ketaminum, Cetamina [INN-Spanish], Ketamine Base, SCHEMBL5512024,NSC-70151,KETAMINE [VANDF],Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+-)-, Tekam,BDBM50044140,DivK1c_000217,Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI), Ketalar, Special K [street name],2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone, YQEZ, DSSTox_GSID_47810,Ketamine Base,(S)-Ketamine,(.+/-.)-Ketamine, Ketaset (TN),Tekam,Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (.+/-.)-, S-Ketamine,Calypsol,NSC 70151, 6740-88-1 (Parent),CHEBI:6121, (2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one, Ketoject, Ketalar base,2-(2-Chlorophenyl)-2-methylamino-cyclohexan-1-one,EINECS 229-804-1,Anaket v,SMR000238141, 2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone,J-505587,2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone(Ketamine), CLSTA 20, cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (2S)-, Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-(9CI), 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI 581 base, l-Ketamine,ketamina,Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI), (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone, CHEBI:60799, Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)-(8CI),Tox21_111704, esketamine HCl,k,DSSTox_GSID_23187, 2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone,ket, Ketolar,Esketamine (S-enantiomer),HSDB 2180,Ketamine,CHEMBL742,Esketamine,KETAMINE [WHO-DD],DEA No. 7285,690G0D6V8H,cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-,Ketaject,Cetamina,6740-88-1,narketan,Ketalar base, 50LFG02TXD,kittens,ketamine, Ketaject, Special K, Ketaminum [INN-Latin],Vetaket, UNII-50LFG02TXD,Imalgene 1000,BRN 2216965


Estimated data

Solubility: -2.981 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 84.7% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.